z-logo
open-access-imgOpen Access
sLe<sup>x</sup> expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator
Author(s) -
Yawen Song,
Hui Sun,
Wu K,
Jianke Lyu,
Jingyue Zhang,
Feng Gu,
Yihui Ma,
Biyu Shen,
Chijuan Wang,
Xiaojiao Chen,
Jing Xu,
Weidong Li,
Fangfang Liu,
Fu Li
Publication year - 2021
Publication title -
cancer biology and medicine
Language(s) - English
Resource type - Journals
ISSN - 2095-3941
DOI - 10.20892/j.issn.2095-3941.2020.0422
Subject(s) - muc1 , immunohistochemistry , immunofluorescence , pathology , medicine , stage (stratigraphy) , mucin , metastasis , sialyl lewis x , oncology , biology , cancer , antibody , inflammation , immunology , paleontology , selectin
Mucin 1 (MUC1/EMA) and sialyl Lewis X (sLe x ) indicate polarity reversal in invasive micropapillary carcinoma (IMPC). The purpose of this study was to evaluate the expression of MUC1/EMA and sLe x and to assess their diagnostic and prognostic value in patients with IMPC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here